Special Seminar:Bernard Arulanandam Ph.D., M.B.A.
Posted: August 3, 2012
Dr. Bernard Arulanandam is a mucosal immunologist and directs a research program that is focused on identifying strategies to induce optimal mucosal protection and immunity. Specifically, his efforts are focused on vaccine development with Chlamydia trachomatis and Francisella tularensis. He has published over 75 research papers and is funded by NIH and DoD. He is currently an Associate Dean of Research for Scientific Innovation. He also directs San Antonio Vaccine Development Center and the DoD Center for Excellence in Infection Genomics.
Bernard Arulanandam Ph.D., M.B.A.
Professor of Microbiology and Immunology
Jane and Roland Blumberg Professor in Biology
Associate Dean of Research for Scientific Innovation
College of Sciences, University of Texas at San Antonio
Contact: Girish Kirimanjeswara 3-5250